Pomegranate | whatsinit

About

What it is and where it shows up.

Pomegranate (Punica granatum L.) is an edible fruit native to regions including Iran, Afghanistan, and China, widely consumed as whole fruit, juice, and extract. It is rich in hydrolysable tannins, anthocyanins, flavonols, ellagic acid, and punicalagin, and is used in food and beverages for its nutritional value, antioxidant properties, and flavour.

Safety summary

The regulatory and scientific consensus.

Pomegranate and its extracts are broadly considered safe for the general adult population, with no established ADI and GRAS status confirmed by the FDA for pomegranate extract in dairy, beverages, and confectionery. However, pomegranate preparations may interact with certain prescription drugs by activating liver enzymes involved in drug metabolism, and health claims related to cholesterol reduction, antioxidant, and anti-aging effects have not been substantiated by EFSA for regulatory approval.

Regulatory landscape

What food-safety regulators have decided.

Jurisdiction	Status	Note
EFSA (European Food Safety Authority) (European Union)	Approved	EFSA reviewed health claims related to pomegranate/pomegranate juice polyphenols (punicalagin, ellagic acid) in relation to blood cholesterol, erectile function, antioxidant, anti-aging, skin, appetite, blood glucose, and weight management; the claims were not substantiated. Pomegranate as a whole fruit/juice ingredient is permitted in the EU food supply with no specific maximum use level restriction as a whole food.source
FSSAI (Food Safety and Standards Authority of India) (India)	Approved	Pomegranate infusion approved under Food Safety and Standards (Approval for Non-Specified Food and Food Ingredients) Regulations, 2017 (Application No. 73/Std/PA/Re-REF15021617/2015/FSSAI/2018). Pomegranate as a whole fruit and juice also recognised under FSSAI fruit and vegetable product standards.source
FDA (Food and Drug Administration) (United States)	Approved	Pomella® Pomegranate Extract (whole fruit pomegranate extract, CAS No. 84961-57-9) affirmed GRAS under GRN No. 1064 for use in dairy products, non-alcoholic beverages, and chocolate candy at 50 mg per serving. Not intended for use in infant formula or foods formulated for infants and young children.source

Who should approach with care

Whose guidance would steer them away.

Heart Disease — Pomegranate preparations may activate liver cytochrome P450 enzymes, potentially altering the metabolism of cardiovascular drugs (e.g., statins, warfarin, ACE inhibitors), necessitating medical consultation.

Liver Disease — Pomegranate extracts at supplemental doses can induce hepatic enzyme activity, which may affect drug metabolism and liver function in patients with pre-existing liver conditions.

Kidney Disease — Pomegranate juice is high in potassium; patients with kidney disease who need to restrict potassium intake should limit consumption and seek dietary guidance.

Infants — FDA GRAS notification for pomegranate extract explicitly excludes infant formula and foods formulated for infants and young children from its approved uses.

Hypertension — Pomegranate juice has documented blood-pressure-lowering effects that may interact additively with antihypertensive medications, warranting medical supervision.

Research citations

The sources behind this verdict.

1FSSAI. List of product(s)/ingredient(s) applications Approved under FSS (Approval for Non-Specified Food and Food Ingredients) Regulations, 2017 — as on 15th April 2026, 2026. fssai.gov.in
2FDA. GRAS Notice No. GRN 001064 — Pomella® Pomegranate Extract (Verdure Sciences), 2023. fda.gov
3PubMed. Food Applications and Potential Health Benefits of Pomegranate and its Derivatives, 2020. ncbi.nlm.nih.gov
4PubMed. Efficacy and Safety of Pomegranate Medicinal Products for Cancer, 2015. ncbi.nlm.nih.gov
5EFSA. Pomegranate/pomegranate juice related health claims — EFSA Scientific Opinion, 2010. efsa.europa.eu

Independently researched5 citations